Optimizing gelatin hydrogels for volumetric 3D bioprinting. Insights from Rousselot’s Jos Olijve on the ENLIGHT bioprinting ...

The most common pathology affecting the pancreas is excess intra-pancreatic ... most have shown promise in preclinical animal models. But only thiazolidinediones, GLP-1 RAs, DPP-4 inhibitors ...

The Tesla Model Y has proven to be one of the brand’s best-selling models - not to mention, the best-selling car in the world - and for the 2026 model year, the Model Y has been elevated to the ...

Just two months after the tech world was upended by the DeepSeek-R1 AI model, Alibaba Cloud has introduced QwQ-32B, an open source large language model (LLM). The Chinese cloud giant describes the ...

Centre for 3D models of Health and Disease, Division of Surgery and Interventional Science, University College London, London W1W 7TY, U.K. Centre for 3D models of Health and Disease, Division of ...

Staff in Microsoft’s artificial intelligence unit recently finished training a new family of AI models, internally dubbed MAI, that they think can perform nearly as well as leading models from labs ...

The model could help test the ability of different drugs in treating pancreatic cancer. Image credit: Shutterstock / Lightspring. A team of German scientists and biotech company Dynamic42 have jointly ...

Image generation startup Stability AI has launched a model that the company says can generate 3D scenes and camera angles from a single 2D image. However, it still struggles with scenes featuring ...

(RTTNews) - Silexion Therapeutics (SLXN) announced positive data from preclinical studies of SIL204, its RNA interference (RNAi) therapy, in orthotopic pancreatic cancer models. These findings ...

spleen and stomach in the two models checked for the various organs, Panc-1 and BxPC-3 models. Subcutaneous administration of SIL204 proved effective in reaching and treating pancreatic tumors and ...

Cell line-specific efficacy profiles: SIL204 showed robust activity across multiple pancreatic cancer ... intestine, spleen and stomach in the two models checked for the various organs, Panc ...

Silexion Therapeutics' Latest Data Demonstrates that Subcutaneously Administered SIL204 Reduces Both Primary Tumors and Metastases in Clinically Relevant Orthotopic Models Where Human Pancreatic ...